Retatrutide 30mg

Retatrutide – 30mg (Lyophilized Powder)

Take your metabolic research further with our high-concentration Retatrutide 30mg. As the most potent "triple agonist" currently in the research landscape, Retatrutide simultaneously targets the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and GCGR (glucagon) receptors. This 30mg vial is designed for high-scale laboratory studies requiring superior potency and consistency.

Product Specifications:

• Peptide Type: Triple Hormone Receptor Agonist

• Concentration: 30mg per vial

• Form: Lyophilized (Freeze-Dried) White Powder

• Purity: >99% (High-Performance Liquid Chromatography verified)

• Storage: Store at -20°C for long-term shelf life. Once reconstituted, maintain at 2°C – 8°C and use within the recommended research window to ensure peptide stability.

Key Research Areas:

• Enhanced Weight Loss Models: Analyzing the superior efficacy of triple-receptor binding compared to single or dual agonists.

• Basal Metabolic Rate (BMR): Studying the glucagon component’s role in increasing energy expenditure.

• Insulin Secretion & Sensitivity: Investigating the glucose-dependent mechanisms of insulin regulation.

• Cardiovascular & Renal Impact: Researching the systemic secondary benefits of potent GLP-1/GIP/Glucagon modulation.

Why Choose Our 30mg Formulation?

Our 30mg vials provide a higher concentration for researchers looking to streamline dosing protocols in larger-scale studies. By utilizing rigorous purification processes, we ensure that every vial contains the precise milligram count with maximum bioactivity and minimal residual solvents.

Disclaimer: This product is intended for laboratory research purposes only. It is not for human consumption, medical, or diagnostic use. Research chemicals are not food products or drugs.